Aevolo Cycling 'shocked and saddened' by Villalobos' positive drug test

Luis Villalobos in the Best Young Rider's jersey at the Larry H. Miller Tour of Utah
(Image credit: Getty Images)

Aevolo Cycling expressed their 'shock' and 'sadness' after learning that their former rider Luis Villalobos tested positive for growth hormone GHRP-6 while he was under contract with their team last year.

The UCI announced Monday that Villalobos returned an Adverse Analytical Finding (AAF) for growth hormone GHRP-6 in a sample collected by the Mexican National Anti-Doping Organisation during an out-of-competition control on April 25, 2019.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1

Cyclingnews is the world's leader in English-language coverage of professional cycling. Started in 1995 by University of Newcastle professor Bill Mitchell, the site was one of the first to provide breaking news and results over the internet in English. The site was purchased by Knapp Communications in 1999, and owner Gerard Knapp built it into the definitive voice of pro cycling. Since then, major publishing house Future PLC has owned the site and expanded it to include top features, news, results, photos and tech reporting. The site continues to be the most comprehensive and authoritative English voice in professional cycling.